• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Cumenes

Recent Advances in the Application of 2-Fluoro-6-(propan-2-yl)aniline (CAS: 126476-48-0) in Chemical Biology and Pharmaceutical Research

The compound 2-fluoro-6-(propan-2-yl)aniline (CAS: 126476-48-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This aromatic amine, characterized by a fluorine substituent and an isopropyl group, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have highlighted its potential in the design of novel kinase inhibitors, antimicrobial agents, and fluorescent probes, underscoring its importance in medicinal chemistry.

One of the most notable advancements involves the use of 2-fluoro-6-(propan-2-yl)aniline as a building block for the development of selective kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its incorporation into a series of pyrimidine-based compounds targeting EGFR (epidermal growth factor receptor) mutations. The fluorine atom at the ortho position was found to enhance binding affinity by forming critical hydrogen bonds with the kinase's hinge region, while the isopropyl group contributed to improved pharmacokinetic properties. These findings suggest that 126476-48-0 could play a pivotal role in addressing drug resistance in cancer therapies.

In antimicrobial research, derivatives of 2-fluoro-6-(propan-2-yl)aniline have shown promising activity against multidrug-resistant bacterial strains. A recent publication in Bioorganic & Medicinal Chemistry Letters reported the synthesis of sulfonamide derivatives using this compound, which exhibited potent inhibition of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The presence of the fluorine atom was crucial for membrane penetration, while the isopropyl group enhanced lipophilicity, leading to improved bacterial uptake. These results highlight the compound's potential as a scaffold for novel antibiotic development.

The unique photophysical properties of 2-fluoro-6-(propan-2-yl)aniline have also been exploited in chemical biology applications. Researchers have utilized this compound as a precursor for fluorescent probes capable of detecting reactive oxygen species (ROS) in cellular environments. A 2024 study in Analytical Chemistry described a ratiometric probe derived from 126476-48-0 that demonstrated high selectivity for hypochlorous acid (HOCl) over other ROS, with a detection limit of 15 nM. This advancement could significantly improve our understanding of oxidative stress-related diseases.

From a synthetic chemistry perspective, recent methodological developments have streamlined the production of 2-fluoro-6-(propan-2-yl)aniline. A novel continuous-flow synthesis approach published in Organic Process Research & Development in 2023 achieved an 89% yield with excellent purity (>99%), addressing previous challenges in large-scale production. This technological advancement is expected to facilitate broader application of this compound in pharmaceutical manufacturing.

In conclusion, 2-fluoro-6-(propan-2-yl)aniline (CAS: 126476-48-0) continues to demonstrate significant value across multiple areas of chemical biology and pharmaceutical research. Its applications in targeted drug discovery, antimicrobial development, and chemical sensing underscore its versatility as a molecular building block. Ongoing research is expected to further expand its utility, particularly in addressing current challenges in precision medicine and infectious disease treatment. Future studies should focus on exploring additional derivatives and optimizing their pharmacological profiles for clinical translation.

• 1260852-77-4(2-Allyl-6-fluoro-4-methylbenzenamine)
• 112121-88-7(Benzenamine,2,4-difluoro-6-(1-methylethyl)-)
• 118939-78-9(Benzenamine, 4-fluoro-2-methyl-N-methylene-6-(1-methylethyl)-)
• 121286-45-1(Benzenamine,4-fluoro-2-methyl-6-(1-methylethyl)-)
• 117336-04-6(Benzenamine, 2,6-diethyl-4-fluoro-)
• 87119-12-8(2-fluoro-4-(propan-2-yl)aniline)
• 331763-37-2(2-Ethyl-4-fluorobenzenamine)
• 1673562-55-4(2,6-Diphenylmethyl-4-fluoroaniline)
• 1386376-43-7(2,6-Di(4-fluorophenyl)methyl-4-methylaniline)
• 1250966-57-4(2-Cyclopropyl-4-fluoroaniline)